2023-04-06 2024-04-05 false Capium Accounts Production 1.1 06218684 bus:FullAccounts 2023-04-06 2024-04-05 06218684 bus:FRS102 2023-04-06 2024-04-05 06218684 bus:AuditExemptWithAccountantsReport 2023-04-06 2024-04-05 06218684 bus:SmallCompaniesRegimeForAccounts 2023-04-06 2024-04-05 06218684 bus:PrivateLimitedCompanyLtd 2023-04-06 2024-04-05 06218684 2023-04-06 2024-04-05 06218684 2024-04-05 06218684 bus:RegisteredOffice 2023-04-06 2024-04-05 06218684 core:WithinOneYear 2024-04-05 06218684 core:AfterOneYear 2024-04-05 06218684 bus:Director1 2023-04-06 2024-04-05 06218684 bus:Director1 2024-04-05 06218684 bus:Director1 2022-04-06 2023-04-05 06218684 2022-04-06 06218684 bus:CompanySecretary1 2023-04-06 2024-04-05 06218684 bus:LeadAgentIfApplicable 2023-04-06 2024-04-05 06218684 2022-04-06 2023-04-05 06218684 2023-04-05 06218684 core:WithinOneYear 2023-04-05 06218684 core:AfterOneYear 2023-04-05 06218684 bus:EntityAccountantsOrAuditors 2022-04-06 2023-04-05 06218684 bus:OrdinaryShareClass1 2023-04-06 2024-04-05 06218684 bus:OrdinaryShareClass1 2024-04-05 06218684 bus:OrdinaryShareClass1 2022-04-06 2023-04-05 06218684 bus:OrdinaryShareClass1 2023-04-05 06218684 core:FurnitureFittings 2023-04-06 2024-04-05 06218684 core:FurnitureFittings 2024-04-05 06218684 core:FurnitureFittings 2023-04-05 06218684 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-04-05 06218684 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-04-05 06218684 core:CostValuation core:Non-currentFinancialInstruments 2024-04-05 06218684 core:CostValuation core:Non-currentFinancialInstruments 2023-04-05 06218684 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-05 06218684 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-05 06218684 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-05 06218684 core:Non-currentFinancialInstruments 2024-04-05 06218684 core:Non-currentFinancialInstruments 2023-04-05 06218684 core:ShareCapital 2024-04-05 06218684 core:ShareCapital 2023-04-05 06218684 core:RetainedEarningsAccumulatedLosses 2024-04-05 06218684 core:RetainedEarningsAccumulatedLosses 2023-04-05 06218684 dpl:Item1 2023-04-06 06218684 dpl:Item1 2024-04-05 06218684 dpl:Item1 2022-04-06 06218684 dpl:Item1 2023-04-05 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 06218684
England and Wales

 

 

 


Filleted Accounts

for the year ended 05 April 2024

for

AKD PHARMA LIMITED

 
 
Notes
 
2024
£
  2023
£
Current assets      
Creditors: amount falling due within one year 4 (677)   (677)
Net current assets (677)   (677)
 
Total assets less current liabilities (677)   (677)
Net assets (677)   (677)
 

Capital and reserves
     
Called up share capital 5 1    1 
Profit and loss account (678)   (678)
Shareholders' funds (677)   (677)
 


For the year ended 05 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 21 October 2024 and were signed by:


-------------------------------
Anthony Coyne
Director
1
General Information
AKD Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 06218684, registration address Penny Lane Business Centre, 374 Smithdown Road, Liverpool, Merseyside, L15 5AN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings 25% Reducing Balance
2.

Average number of employees


Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Total
  £   £
At 06 April 2023 620    620 
Additions  
Disposals  
At 05 April 2024 620    620 
Depreciation
At 06 April 2023 620    620 
Charge for year  
On disposals  
At 05 April 2024 620    620 
Net book values
Closing balance as at 05 April 2024  
Opening balance as at 06 April 2023  


4.

Creditors: amount falling due within one year

2024
£
  2023
£
Accrued Expenses 208    208 
Directors' Current Accounts 469    469 
677    677 

5.

Share Capital

Authorised
1 Ordinary share of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
1 Ordinary share of £1.00 each  
 

2